Back
29
Day Range
$36.80
$37.67
52-Week Range
$19.17
$37.67
Volume
225,950
50D / 200D Avg
$32.28
/
$27.21
Prev Close
$37.26
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 48.4 | 0.3 |
| P/B | 11.6 | 2.9 |
| ROE % | 28.3 | 3.7 |
| Net Margin % | 3.4 | 3.8 |
| Rev Growth 5Y % | 16.3 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$36.00
-4.2%
Low: $30.00
High: $40.00
Forward P/E
30.2
Forward EPS
$1.24
EPS Growth (est.)
+0.0%
Est. Revenue
1.4 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.46
$1.44 – $1.48
|
1.7 B | 2 |
| FY2027 |
$1.36
$1.31 – $1.40
|
1.5 B | 3 |
| FY2026 |
$1.24
$1.21 – $1.25
|
1.4 B | 3 |
Key Takeaways
Revenue grew 16.29% annually over 5 years — strong growth
ROE of 28.25% indicates high profitability
Debt/Equity of 0.22 — conservative balance sheet
Generating 80.71M in free cash flow
P/E of 48.35 — premium valuation
Cash machine — converts 163.98% of earnings into free cash flow
Growth
Revenue Growth (5Y)
16.29%
Revenue (1Y)17.93%
Earnings (1Y)N/A
FCF Growth (3Y)19.77%
Quality
Return on Equity
28.25%
ROIC26.62%
Net Margin3.40%
Op. Margin6.14%
Safety
Debt / Equity
0.22
Current Ratio1.38
Interest Coverage133.71
Valuation
P/E Ratio
48.35
P/B Ratio11.57
EV/EBITDA26.53
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17.93% | Revenue Growth (3Y) | 17.67% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 43.50% |
| Revenue Growth (5Y) | 16.29% | Earnings Growth (5Y) | 31.79% |
| Profitability | |||
| Revenue (TTM) | 1.45B | Net Income (TTM) | 49.22M |
| ROE | 28.25% | ROA | 11.93% |
| Gross Margin | 19.47% | Operating Margin | 6.14% |
| Net Margin | 3.40% | Free Cash Flow (TTM) | 80.71M |
| ROIC | 26.62% | FCF Growth (3Y) | 19.77% |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 1.38 |
| Interest Coverage | 133.71 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 48.35 | P/B Ratio | 11.57 |
| P/S Ratio | 1.64 | PEG Ratio | -0.26 |
| EV/EBITDA | 26.53 | Dividend Yield | 0.00% |
| Market Cap | 2.38B | Enterprise Value | 2.36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.45B | 1.23B | 1.05B | 908.91M | 792.07M |
| Net Income | 49.22M | -87.29M | 23.90M | 35.42M | 16.31M |
| EPS (Diluted) | 0.78 | -1.77 | 0.39 | 0.58 | 0.27 |
| Gross Profit | 282.04M | 244.37M | 208.31M | 185.87M | 161.27M |
| Operating Income | 88.91M | -62.92M | 40.95M | 51.99M | 30.15M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 412.66M | 320.81M | 271.17M | 256.11M | 235.85M |
| Total Liabilities | 194.73M | 170.83M | 211.31M | 180.18M | 182.53M |
| Shareholders' Equity | 205.76M | 142.67M | 28.21M | 42.73M | 23.93M |
| Total Debt | 44.72M | 37.33M | 69.15M | 62.98M | 55.04M |
| Cash & Equivalents | 65.62M | 4.66M | 752,000.0 | 607,000.0 | 15.01M |
| Current Assets | 221.63M | 151.99M | 129.60M | 120.00M | 111.87M |
| Current Liabilities | 160.70M | 144.12M | 138.02M | 112.01M | 111.54M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#856 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026